BMO Capital Markets resumed coverage on Sundial Growers with a new price target
$SNDL
Medicinal Chemicals and Botanical Products
Health Care
BMO Capital Markets resumed coverage of Sundial Growers with a rating of Underperform and set a new price target of $0.40